全文获取类型
收费全文 | 28161篇 |
免费 | 1888篇 |
国内免费 | 477篇 |
专业分类
耳鼻咽喉 | 643篇 |
儿科学 | 420篇 |
妇产科学 | 441篇 |
基础医学 | 4701篇 |
口腔科学 | 363篇 |
临床医学 | 2208篇 |
内科学 | 6019篇 |
皮肤病学 | 1063篇 |
神经病学 | 2141篇 |
特种医学 | 1823篇 |
外科学 | 3591篇 |
综合类 | 138篇 |
一般理论 | 10篇 |
预防医学 | 910篇 |
眼科学 | 665篇 |
药学 | 2408篇 |
中国医学 | 334篇 |
肿瘤学 | 2648篇 |
出版年
2023年 | 188篇 |
2022年 | 633篇 |
2021年 | 993篇 |
2020年 | 550篇 |
2019年 | 726篇 |
2018年 | 871篇 |
2017年 | 734篇 |
2016年 | 1130篇 |
2015年 | 1602篇 |
2014年 | 1782篇 |
2013年 | 1924篇 |
2012年 | 2821篇 |
2011年 | 2672篇 |
2010年 | 1696篇 |
2009年 | 1365篇 |
2008年 | 1796篇 |
2007年 | 1596篇 |
2006年 | 1398篇 |
2005年 | 1256篇 |
2004年 | 1008篇 |
2003年 | 901篇 |
2002年 | 778篇 |
2001年 | 315篇 |
2000年 | 303篇 |
1999年 | 237篇 |
1998年 | 133篇 |
1997年 | 113篇 |
1996年 | 77篇 |
1995年 | 53篇 |
1994年 | 39篇 |
1993年 | 44篇 |
1992年 | 61篇 |
1991年 | 85篇 |
1990年 | 54篇 |
1989年 | 62篇 |
1988年 | 62篇 |
1987年 | 65篇 |
1986年 | 35篇 |
1985年 | 38篇 |
1984年 | 22篇 |
1983年 | 29篇 |
1982年 | 14篇 |
1980年 | 17篇 |
1979年 | 30篇 |
1978年 | 32篇 |
1977年 | 33篇 |
1976年 | 18篇 |
1975年 | 15篇 |
1974年 | 15篇 |
1971年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
Kang JH Farina A Park JH Kim SH Kim JY Rizzo N Elmakky A Jun HS Hahn WB Cha DH 《Prenatal diagnosis》2008,28(8):704-709
OBJECTIVES: To estimate the combined screening performance of first and early second trimester prenatal serum markers for Down syndrome, in screening for the development of preeclampsia, and analyze the correlation among marker levels, week of onset, and severity of the disease. METHODS: A retrospective cohort study was carried out on 32 women with preeclampsia and 3044 controls. Serum samples from these pregnancies were assayed for pregnancy-associated plasma protein-A (PAPP-A), alpha-fetoprotein (AFP), unconjugated estriol (uE3), human chorionic gonadotrophin (hCG), and inhibin-A. A likelihood ratio and the odds of being affected given a positive result (OAPR) of various combinations of markers were calculated and receiver operating characteristic (ROC) curves analysis was performed. RESULTS: In the pregnancies that subsequently developed preeclampsia, first trimester PAPP-A concentration was significantly lower and concentrations of early second trimester inhibin-A and hCG significantly elevated. Levels of early second trimester uE3 and AFP were not significantly altered. We also found that inhibin-A correlates with both onset of the disease and the severity. CONCLUSION: Down syndrome biochemical markers levels are altered in those patients who subsequently developed preeclampsia and may be a useful screening test for preeclampsia. Inhibin-A is the most predictive marker and correlates with the severity of subsequent preeclampsia and inversely with the week of occurrence of preeclampsia. 相似文献
104.
Park IY Jo YS Shin JC Sung IK Kim M 《The journal of obstetrics and gynaecology research》2008,34(1):85-87
A 32-year-old woman at 17 weeks of gestation had a high possibility (1:82) of having a child with Down syndrome. Fetal chromosome according to amniocentesis revealed 46,XX,del(7)(q11.23q21.2). The fetus' chromosomal defect was not inherent because the chromosome analysis of the parents did not have any abnormal findings. We were regularly monitoring the pregnant woman by routine prenatal schedule and she had a normal spontaneous delivery. The baby showed a typical facial malformation, epicanthal fold, decreased muscle tone, and cardiac abnormalities. This is the first patient prenatally diagnosed with de novo 7q deletion by positive triple marker screening test. We consider the triple test, which is the most popular examination used to clarify the risk of chromosome abnormality in obstetrics, will be used not only for trisomy 21 and 18, but also for any other chromosome abnormalities. 相似文献
105.
Chung HH Jo H Kang WJ Kim JW Park NH Song YS Chung JK Kang SB Lee HP 《Gynecologic oncology》2007,104(3):529-534
OBJECTIVES: To assess the value and clinical impact of integrated PET/CT using (18)F-FDG in the diagnosis and management of women with suspected cervical cancer recurrence. METHODS: Fifty-two patients with cervical cancer with suspected recurrence because of clinical, cytological, biochemical and radiological findings were retrospectively evaluated. A final diagnosis of recurrence was confirmed by histologic tissue biopsy or by further clinical or radiological evidence. The clinical impact of information provided by PET/CT on patient management was assessed on the basis of clinical follow-up data concerning further diagnostic or therapeutic approach. RESULTS: Twenty-eight of 32 positive PET/CT scans (87.5%) were proven to have recurrent disease. Seventeen of 20 negative PET/CT scans (85.0%) had no evidence of disease. The sensitivity, specificity, and accuracy of PET/CT for detecting recurrence were 90.3%, 81.0%, and 86.5% respectively. PET/CT changed the management of 12 patients (23.1%) by changing treatment plan (5 patients), by initiating unplanned treatment strategy (4 patients), or by obviating the need for planned diagnostic procedures (3 patients). Median duration after performing PET/CT and last follow-up was 12 (range: 6-27) months, and the 2-year disease-free survival rate of patients with negative PET/CT scan for recurrence was significantly better than that of patients with positive PET/CT (85.0% vs. 10.9%, P=0002). CONCLUSIONS: In patients with a suspected recurrence of cervical cancer, integrated PET/CT using (18)F-FDG provides good anatomic and functional localization of suspicious lesions, and the better diagnostic interpretation has an impact not only on clinical management and treatment planning of patients, but also on disease-free survival. 相似文献
106.
OBJECTIVES: The purpose of our study is to provide reference values for the great vessels obtained from images of the three-vessel view of the fetal heart, with an emphasis on the size discrepancy of the great vessels. METHODS: From February 2003 to May 2003, the main pulmonary artery (MPA), ascending aorta (AA), and SVC were measured in well-dated, nonanomalous fetuses scanned at 14-38 weeks of gestation. RESULTS: The size of each great vessel had a significant positive relationship with advance in gestation (P < 0.001); MPA (mm) = -2.76 + 0.34 x GA, ascending aorta (AA) (mm) = -1.73 + 0.26 x GA - 1.18E - 05 x GA(3), and SVC (mm) = 0.33 + 0.01 x GA(2) - 4.12E - 05 x GA(3). The AA/MPA ratio was significantly decreased with advance in gestation, while the SVC/AA ratio was significantly increased; AA/MPA ratio = -1.24 - 0.03 x GA + 3.88E - 04 x GA(2); P < 0.001, SVC/AA ratio = 0.63 - 5.43E - 03 x GA + 1.96E - 04 x GA(2); P < 0.001. CONCLUSION: On the three-vessel view of the fetal heart, the interpretation of the size discrepancy of the great vessels needs to be adjusted according to fetal growth. 相似文献
107.
108.
Sang Young Kim Jung Hyun Kwak Chang Soo Eun Dong Soo Han Yong Sung Kim Kyu Sang Song Bo Youl Choi Hyun Ja Kim 《Nutrients》2022,14(11)
The incidence of gastric cancer is high in Korea, and dietary factors are important risk factors for gastric cancer. This study examined whether gastric cancer risk was related to dietary factors that directly irritate the stomach wall. This case–control study consisted of 308 matched pairs of gastric cancer cases and controls recruited from 2002 to 2006 at two hospitals in Korea. Dietary assessments were completed using a food frequency questionnaire and a dietary habit questionnaire. Gastric cancer risk was increased for high meal frequency of >3 vs. low meal frequency of ≤3 times per day, overeating vs. not overeating, and preferred vs. not preferred spicy or salty foods. Furthermore, participants with dietary factors of high meal frequency, overeating, and preference for spicy or salty foods elevated the risk of gastric cancer compared to those with low meal frequency, not overeating, and not preferring spicy or salty foods, simultaneously. In conclusion, gastric cancer risk was significantly increased in people with dietary factors that irritate the stomach wall, such as high meal frequency, overeating, and preference for spicy or salty foods. 相似文献
109.
Jing Ying Lim Roslee Rajikan Noh Amit Nazlena Mohamad Ali Haslina Abdul Hamid Huey Yin Leong Maslina Mohamad Bi Qi Koh Aini Musa 《Nutrients》2022,14(12)
Dietary intervention is generally accepted as the mainstay of treatment for patients with disorders of amino acid metabolism (AAMDs). However, dietary adherence to a low-protein diet is always reported as a common challenge among these patients. This study explored the perception of barriers and motivators to dietary adherence among caregivers of AAMD patients in Malaysia. Twenty caregivers of children with AAMDs receiving ongoing treatment at the genetic clinic participated in an online focus group discussion from November to December 2021. Findings showed a total of five interrelated main themes identified from focus group discussion (FGD) exploring parents’ experiences related to the management of their child’s daily diet. The barriers to dietary adherence were burden of dietary treatment, diet and dietary behavior, parenting challenges, limited knowledge related to dietary treatment, and challenges in healthcare system delivery. Key factors facilitating good dietary adherence include good knowledge of dietary treatment, parental coping strategies, social coping, and dietary behavior. In conclusion, despite the existence of several barriers to the implementation of dietary treatment, caregivers managed to use a wide range of coping strategies to overcome some, if not all, of the challenges. The important next step is to develop, in conjunction with multidisciplinary healthcare professionals, feasible implementation strategies that could address these barriers and at the same time improve the quality of life of caregivers. 相似文献
110.
Yoo Na Jang Yong Jik Lee Yoon Mi Han Hyun Min Kim Hong Seog Seo Ji Hoon Jeong Seung Yeon Park Tae Woo Jung 《Yonsei medical journal》2022,63(6):530
PurposeSince diabetes and hypertension frequently occur together, it is thought that these conditions may have a common pathogenesis. This study was designed to evaluate the anti-diabetic function of the anti-hypertensive drug fimasartan on C2C12 mouse skeletal muscle and HepG2 human liver cells in a high glucose state.Materials and MethodsThe anti-diabetic effects and mechanism of fimasartan were identified using Western blot, glucose uptake tests, oxygen consumption rate (OCR) analysis, adenosine 5′-triphosphate (ATP) enzyme-linked immunosorbent assay (ELISA), and immunofluorescence staining for diabetic biomarkers in C2C12 cells. Protein biomarkers for glycogenolysis and glycogenesis were evaluated by Western blotting and ELISA in HepG2 cells.ResultsThe protein levels of phosphorylated 5′ adenosine monophosphate-activated protein kinase (p-AMPK), p-AKT, insulin receptor substrate-1 (IRS-1), and glucose transporter type 4 (Glut4) were elevated in C2C12 cells treated with fimasartan. These increases were reversed by peroxisome proliferator-activated receptor delta (PPARδ) antagonist. ATP, OCR, and glucose uptake were increased in cells treated with 200 µM fimasartan. Protein levels of glycogen phosphorylase, glucose synthase, phosphorylated glycogen synthase, and glycogen synthase kinase-3 (GSK-3) were decreased in HepG2 cells treated with fimasartan. However, these effects were reversed following the addition of the PPARδ antagonist GSK0660.ConclusionIn conclusion, fimasartan ameliorates deteriorations in glucose metabolism as a result of a high glucose state by regulating PPARδ in skeletal muscle and liver cells. 相似文献